Our Technological Platforms
Technological innovation is essential for uncovering the mechanisms behind tumor development and for identifying advanced diagnostic and therapeutic solutions. In this context, IFOM hosts several state-of-the-art technology units that provide crucial support to research groups. These units employ cutting-edge tools to explore new therapies and deepen the understanding of cancer causes. Thanks to the Athena strategic plan, in 2023 our institute acquired several innovative technologies. IFOM also pursues technological excellence through Cogentech, its Benefit Corporation. Cogentech’s mission is to provide advanced technologies and qualified personnel for research and diagnostics, adapting to the needs of research partners. It offers diagnostic services for hereditary cancers and personalized medicine, as well as advanced technological services for physicians, laboratories, and hospitals.
